financetom
Business
financetom
/
Business
/
Tilray Brands Outlines Possible Growth Avenues in Cannabis Sector
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tilray Brands Outlines Possible Growth Avenues in Cannabis Sector
Oct 17, 2025 4:52 AM

07:20 AM EDT, 10/17/2025 (MT Newswires) -- Tilray Brands ( TLRY ) said Friday it aims to see future growth in the cannabis sector boosted by expanded cannabis offerings in healthcare, on-site consumption of THC beverages, and policies that will promote competitiveness.

"While significant strides have been made, there is still important work to be done to further advance and refine regulations in Canada, ensuring the continued growth and success of the industry," the company said in a statement.

Tilray said its diversified platform is positioned to capitalize on future industry growth, with 5 million square feet of advanced cannabis cultivation facilities and current production of 210 metric tons.

Tilray shares are down $0.04, to $1.50, in U.S. pre-market trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nissan paid ex-operations chief $3.7 million over departure
Nissan paid ex-operations chief $3.7 million over departure
May 31, 2024
YOKOHAMA, Japan (Reuters) - Nissan Motor ( NSANF ) paid former Chief Operating Officer Ashwani Gupta $3.7 million in compensation following his sudden departure last year, the Japanese automaker disclosed in a notice for its annual general meeting. Nissan ( NSANF ) said in the notice it had paid 582 million yen ($3.7 million) to an executive officer who left...
Champion Iron Q4 Net Income Drops 71%
Champion Iron Q4 Net Income Drops 71%
May 31, 2024
06:29 AM EDT, 05/31/2024 (MT Newswires) -- Champion Iron ( CIAFF ) overnight Thursday reported a 71% decrease in fourth-quarter net income as revenue declined. Net income for the three months ended March 31 came in at 28.5 million, or $0.05 per share, down from $88.2 million, or $0.17 per share. Revenue decreased 28% to $332.7 million from $463.9 million....
EU regulator recommends use of Pfizer's gene therapy for rare bleeding disorder
EU regulator recommends use of Pfizer's gene therapy for rare bleeding disorder
May 31, 2024
May 31 (Reuters) - The European Medicines Agency has recommended the use of Pfizer's ( PFE ) gene therapy for a rare bleeding disorder called hemophilia B, which typically requires regular infusions of a blood-clotting protein, the regulator said on Friday. ...
What's Going On With Palantir Technologies Stock Today?
What's Going On With Palantir Technologies Stock Today?
May 31, 2024
Palantir Technologies Inc. ( PLTR ) shares are trading higher in the premarket session on Friday after ending yesterday’s run with a nearly 4% jump. Yesterday, after the closing bell,  the company announced that the Department of Defense Chief Digital and Artificial Intelligence Office (CDAO) awarded its subsidiary, Palantir USG, a production contract. The order pertains to making licenses of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved